US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes; Trijardy(TM) XR (empagliflozin/linagliptin/metformin hydrochloride extended release tablets) is a once-daily therapy combining three well-established treatment

Press/Media: Press / Media

PeriodJan 27 2020 → Jan 28 2020

Media coverage

29

Media coverage

  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletJotup
    CountryUnited States
    Date1/28/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletNasdaq
    CountryUnited States
    Date1/28/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletPipelineReview
    CountrySpain
    Date1/28/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance for adults with type 2 diabetes
    Media name/outletFirstWord Pharma
    CountryUnited States
    Date1/28/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes; Trijardy(TM) XR (empagliflozin/linagliptin/metformin hydrochloride extended release tablets) is a once-daily therapy combining three well-established treatment
    Media name/outletPR Newswire
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    CountryJordan
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes; Trijardy(TM) XR (empagliflozin/linagliptin/metformin hydrochloride extended release tablets) is a once-daily therapy combining three well-established treatment
    Media name/outletPR Newswire
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletPR Newswire
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletMorningstar.com
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletBioSpace
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletFinanzen.ch
    CountrySwitzerland
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleELI LILLY AND : US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletMarketScreener.com
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance ® for adults with type 2 diabetes
    Media name/outletStockwatch
    CountryCanada
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletTickerTech.com
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletMarket Newsdesk
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet...
    Media name/outletADVFN Deutschland
    CountryGermany
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletMarkets Business Insider
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • Title$LLY US FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletOTC Dynamics
    CountryCanada
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleFDA Approves Trijardy XR (empagliflozin/linagliptin/metformin) for Type 2 Diabetes in Adults
    Media name/outletDrugs.com
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletSpoke.com
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletProfitQuotes.com
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletEli Lilly
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletKPVI
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletWFMZ-TV Online
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletBranfordSeven.com
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletWBOC TV 16
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletWICZ
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletVB Profiles
    CountryUnited States
    Date1/27/20
    PersonsRalph A Defronzo
  • TitleUS FDA approves only triple-combination tablet with Jardiance® for adults with type 2 diabetes
    Media name/outletCentral Charts
    CountryFrance
    Date1/27/20
    PersonsRalph A Defronzo